Impact of COVID-19 lockdown on hospital admissions for epistaxis in Germany  

作　　者：Adrian Hoenle Martin Wagner Stephan Lorenz Helmut Steinhart 

机构地区：[1]Department of Ear,Nose and Throat,Head and Neck Surgery,Marienhospital Stuttgart,Stuttgart 70199,Germany [2]Department of Emergency Medicine,Katharinenhospital Stuttgart,Stuttgart 70174,Germany

出　　处：《World Journal of Methodology》2023年第5期446-455,共10页世界方法学杂志

摘　　要：BACKGROUND Reports of a decrease in hospital admissions during the coronavirus disease 2019(COVID-19)lockdown period have raised concerns about delayed or missed diagnoses and treatments for non-COVID-19-related illnesses.AIM To investigate the impact of the COVID-19 pandemic-induced lockdown and its end on hospital admissions of patients with epistaxis in Germany.METHODS A retrospective analysis based on the national database of the Hospital Remuneration System was used to compare hospital admissions during defined time periods between 2019 and 2022 with the lockdown period as the reference period.This was done on a weekly basis before,during,and after the lockdown.An Interrupted Time Series was used as the analysis method.RESULTS In our analysis,we included 26183 patients.The implementation of the lockdown led to a substantial reduction in the overall occurrence of epistaxis among patients(P<0.05).This effect was most pronounced in the age group of 0-39 years,where the decrease was highly significant(P<0.001).However,there was no change observed in patients aged 80 years and older(not significant).With the end of the lockdown period,the overall number of patients,especially in the youngest age group,increased abruptly and significantly(P<0.01).CONCLUSION During the lockdown period,there was a decrease in hospital admissions for younger patients with epistaxis,possibly due to the fear of COVID-19 exposure.We also conclude that the severity of epistaxis was not underestimated in the elderly during the pandemic.

关 键 词：COVID-19 EPISTAXIS Lockdown PANDEMIC Emergency medicine OTOLARYNGOLOGY 

分 类 号：R73[医药卫生—肿瘤]